$KNW: (QUICK READ)
Know Labs ($KNW) Power Move Incoming New CEO Greg Kidd — early investor in Twitter, and Ripple — is injecting 1,000 Alternative assets into Know Labs. That’s over $109 million in Alt assets hitting the books of a company with a current market cap around $20M.
Bull Flag + Short Squeeze Setup: The stock gapped up hard from $0.50 to $1.50 on the announcement, triggering a short trap. Now consolidating near $3, it's forming a textbook bull flag — and squeeze pressure is building.
Valuation Case:
Market cap: ~$20M
Alt assets injection alone suggests valuation of $110M+
With alt assets on balance sheet, a fair minimum valuation is $110M+, or $15–$20+/share — and that’s not even including the value of their patent portfolio of over 300 patents and the global leader in IP in non invasive blood glucose monitoring.
The Real Moat: Know Labs holds the world’s largest patent portfolio for non-invasive blood glucose monitoring, a game-changing healthcare innovation with billion-dollar potential. This is deep tech meets tech, led by a visionary operator.
CREDIT: Poster Maent. Highly regarded w/history of big rip winners. 8/13/25 6:50am. EST
Know Labs ($KNW) Power Move Incoming New CEO Greg Kidd — early investor in Twitter, and Ripple — is injecting 1,000 Alternative assets into Know Labs. That’s over $109 million in Alt assets hitting the books of a company with a current market cap around $20M.
Bull Flag + Short Squeeze Setup: The stock gapped up hard from $0.50 to $1.50 on the announcement, triggering a short trap. Now consolidating near $3, it's forming a textbook bull flag — and squeeze pressure is building.
Valuation Case:
Market cap: ~$20M
Alt assets injection alone suggests valuation of $110M+
With alt assets on balance sheet, a fair minimum valuation is $110M+, or $15–$20+/share — and that’s not even including the value of their patent portfolio of over 300 patents and the global leader in IP in non invasive blood glucose monitoring.
The Real Moat: Know Labs holds the world’s largest patent portfolio for non-invasive blood glucose monitoring, a game-changing healthcare innovation with billion-dollar potential. This is deep tech meets tech, led by a visionary operator.
CREDIT: Poster Maent. Highly regarded w/history of big rip winners. 8/13/25 6:50am. EST
